As previously reported, Northland analyst Nehal Chokshi upgraded Nutanix (NTNX) to Outperform from Market Perform with a price target of $97, up from $77. January quarter incremental ARR being “impressively” up 27% year-over-year signals that ARR growth is likely inflecting up and April quarter guidance that was “healthily above consensus” is pointing toward ARR growth likely inflecting up as well, the analyst tells investors in a post-earnings note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTNX:
- Nutanix: Strong Performance and Promising Prospects Justify Buy Rating
- Nutanix price target raised to $88 from $83 at Piper Sandler
- Nutanix: Strong Market Position and Growth Prospects Justify Buy Rating
- Nutanix price target raised to $85 from $75 at Wells Fargo
- Nutanix price target raised to $90 from $83 at JPMorgan